What Lonza’s $1.2B Buy of Roche Biologics Plant Means for CDMO Market

The Swiss contract manufacturer’s cash deal for Roche’s facility in Vacaville, California, is one of the world’s largest manufacturing sites for biologics—a major growth driver for Lonza and other CDMOs.

Scroll to Top